Future Technology Research Center, KT&G Corporation, 30, Gajeong-ro, Yuseong-gu, Daejeon 34128, Republic of Korea.
KM Convergence Research Division, Korea Institute of Oriental Medicine, Yuseong-daero 1672, Daejeon 34054, Republic of Korea.
Nutrients. 2023 Oct 9;15(19):4302. doi: 10.3390/nu15194302.
L., known as European dill, is a versatile herb widely used in both traditional medicine and culinary practices. Despite its long-standing history, the potential impact of the water extract of seeds (WEAG) on bone health remains unexplored. In this study, we investigated the influence of WEAG on osteoclast differentiation and assessed its potential as an anti-osteoporotic agent. WEAG hindered osteoclast differentiation through the suppression of receptor activator of nuclear factor-κB ligand (RANKL) expression in osteoclast-supporting cells and by directly targeting osteoclast precursor cells. WEAG significantly reduced the expression of key osteoclastogenic transcription factors, namely c-Fos and NFATc1, typically induced by RANKL in osteoclast precursors. This reduction was attributed to the suppression of both MAPKs and NF-κB pathways in response to RANKL. In vivo experiments further revealed that WEAG administration effectively reduces trabecular bone loss and weight gain triggered by ovariectomy, mimicking postmenopausal osteoporosis. Furthermore, our comprehensive phytochemical analysis of WEAG identified a range of phytochemical constituents, associated with bone health and weight regulation. Notably, we discovered a specific compound, isorhamnetin-3-O-glucuronide, within WEAG that exhibits anti-osteoclastogenic potential. Overall, this research elucidated the beneficial effects and mechanistic basis of WEAG on osteoclast differentiation and bone loss, indicating its potential as a viable alternative to address bone loss in conditions like postmenopause.
L.,俗称欧洲莳萝,是一种用途广泛的草药,在传统医学和烹饪实践中都有广泛应用。尽管其历史悠久,但种子水提取物 (WEAG) 对骨骼健康的潜在影响仍未得到探索。在这项研究中,我们研究了 WEAG 对破骨细胞分化的影响,并评估了其作为抗骨质疏松剂的潜力。WEAG 通过抑制破骨细胞支持细胞中核因子-κB 受体激活剂配体 (RANKL) 的表达,并直接靶向破骨细胞前体细胞,来抑制破骨细胞分化。WEAG 显著降低了关键破骨细胞生成转录因子 c-Fos 和 NFATc1 的表达,这些转录因子通常在破骨细胞前体细胞中由 RANKL 诱导。这种减少归因于 MAPKs 和 NF-κB 通路的抑制,以响应 RANKL。体内实验进一步表明,WEAG 给药可有效减少卵巢切除引起的小梁骨丢失和体重增加,模拟绝经后骨质疏松症。此外,我们对 WEAG 的综合植物化学分析确定了一系列与骨骼健康和体重调节相关的植物化学成分。值得注意的是,我们在 WEAG 中发现了一种特定的化合物,即异鼠李素-3-O-葡萄糖醛酸苷,它具有抗破骨细胞生成的潜力。总的来说,这项研究阐明了 WEAG 对破骨细胞分化和骨丢失的有益作用和机制基础,表明其作为一种可行的替代方案,可用于解决绝经后等情况下的骨丢失问题。